Olga Lyublinskaya

Dr. Olga Lyublinskaya

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Cell Metabolism
Verified
Journal Article
Closed access
VPValeriy V. Pak
Valeriy V. Pak
DEDaria Ezeriņa
Daria Ezeriņa
OLOlga Lyublinskaya
Olga Lyublinskaya
BPBrandán Pedre
Brandán Pedre
Pyotr Tyurin-KuzminPyotr Tyurin-Kuzmin
Pyotr Tyurin-Kuzmin
VBVsevolod Belousov
Vsevolod Belousov

1 June 2019 in Redox Biology
Verified
Journal Article
Open access
OLOlga Lyublinskaya
Olga Lyublinskaya
FAFernando Antunes
Fernando Antunes
In this study, we propose a method for quantification of average hydrogen peroxide concentration within a living cell that is based on the use of genetically encoded H2O2 biosensor HyPer. The method utilizes flow cytometric measurements of HyPer fluorescence in H2O2-exposed cells to analyze the biosensor oxidation kinetics. Fitting the experimental curves with kinetic equations allows determining the rate constants of HyPer oxidation/reduction which are used further for the calculation of peroxide concentrations in the cells of interest both in the presence and absence of external H2O2. Applying this method to K562 cells, we have estimated the gradient as about 390-fold between the extracellular and intracellular level of exogenous H2O2 in cells exposed to the micromole doses of peroxide, as well as the average basal level of H2O2 in the cytosol of undisturbed cells ( [Formula: see text] ). The method can be extended to other H2O2-sensitive redox probes or to procedures in which, rather than adding external peroxide, intracellular production of peroxide is triggered, providing a tool to quantitate not only basal average H2O2 concentrations but also the concentration of peroxide build up in the vicinity of redox probes.

4 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJulia Kornienko
Julia Kornienko
ISI. S. Smirnova
I. S. Smirnova
NPN. A. Pugovkina
N. A. Pugovkina
JIJu. S. Ivanova
Ju. S. Ivanova
MSM. A. Shilina
M. A. Shilina
OLOlga Lyublinskaya
Olga Lyublinskaya
Stress-induced premature senescence program is known to be activated in cells by various genotoxic stressors, and oxidative stress is considered to be the main of those. To this end, many studies discover antioxidants as protective anti-aging agents. In the current study, we examined the effects of different antioxidants (Tempol, resveratrol, NAC, DPI) on the mesenchymal stem cells maintained in normal physiological conditions. We used high, but non-cytotoxic antioxidant doses which are widely used in laboratory practice to protect cells from oxidative damage. We show that these substances induce reversible block of cell proliferation and do not cause any genotoxic effects when applied to the quiescent cells. However, the same doses of the same substances, when applied to the proliferating cells, can induce irreversible cell cycle arrest, DNA strand breaks accumulation and DNA damage response activation. As a consequence, antioxidant-induced DNA damage results in the stress-induced premature senescence program activation. We conclude that high doses of antioxidants, when applied to the proliferating cells that maintain physiological levels of reactive oxygen species, can cause DNA damage and induce premature senescence which suggests to re-estimate believed unconditional anti-aging antioxidant properties.

1 August 2017 in Redox Biology
Verified
Journal Article
Open access
OLOlga Lyublinskaya
Olga Lyublinskaya
JIJulia Ivanova
Julia Ivanova
NPN.A. Pugovkina
N.A. Pugovkina
IKIrina Kozhukharova
Irina Kozhukharova
ZKZ.V. Kovaleva
Z.V. Kovaleva
NNN.N. Nikolsky
N.N. Nikolsky
Stem cells are believed to maintain a specific intracellular redox status through a combination of enhanced removal capacity and limited production of ROS. In the present study, we challenge this assumption by developing a quantitative approach for the analysis of the pro- and antioxidant ability of human embryonic stem cells in comparison with their differentiated descendants, as well as adult stem and non-stem cells. Our measurements showed that embryonic stem cells are characterized by low ROS level, low rate of extracellular hydrogen peroxide removal and low threshold for peroxide-induced cytotoxicity. However, biochemical normalization of these parameters to cell volume/protein leads to matching of normalized values in stem and differentiated cells and shows that tested in the present study cells (human embryonic stem cells and their fibroblast-like progenies, adult mesenchymal stem cells, lymphocytes, HeLa) maintain similar intracellular redox status. Based on these observations, we propose to use ROS concentration averaged over the cell volume instead of ROS level as a measure of intracellular redox balance. We show that attempts to use ROS level for comparative analysis of redox status of morphologically different cells could lead to false conclusions. Methods for the assessment of ROS concentration based on flow cytometry analysis with the use of H2DCFDA dye and HyPer, genetically encoded probe for hydrogen peroxide, are discussed.

26 February 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
ADAlisa Domnina
Alisa Domnina
PNPolina Novikova
Polina Novikova
JOJulia Obidina
Julia Obidina
IFIrina Fridlyanskaya
Irina Fridlyanskaya
LALarisa Alekseenko
Larisa Alekseenko
NNNikolay Nikolsky
Nikolay Nikolsky
Asherman’s syndrome (AS) is one of the gynecological disorders caused by the destruction of the endometrium. For some cases of AS available surgical methods and hormonal therapy are ineffective. Stem cell transplantation may offer a potential alternative for AS cure. Human endometrial mesenchymal stem cells (eMSC) organized in spheroids were transplanted in rats with damaged endometrium modeled on AS. Treatment response was defined as pregnancy outcome and litter size. Application of eMSC in spheroids significantly improved the rat fertility with the AS model. eMSC organized in spheroids retain all properties of eMSC in monolayer: growth characteristics, expression of CD markers, and differentiation potential. Synthesis of angiogenic and anti-inflammatory factors drastically increased in eMSC assembled into spheroids. Human endometrial mesenchymal stem cells (eMSC) can be successfully applied for Asherman’s syndrome (AS) treatment in the rat model. eMSC organized in spheroids were more therapeutically effective than the cells in monolayer. After transplantation of eMSC in spheroids the pregnancy outcome and litter size in rats with AS was higher than in rats that received autologous rat bone marrow cells. It suggests the therapeutic plausibility of heterologous eMSC in case of failure to use autologous cells.

1 January 2015 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
OLOlga Lyublinskaya
Olga Lyublinskaya
YBYa. G. Borisov
Ya. G. Borisov
NPN. A. Pugovkina
N. A. Pugovkina
ISI. S. Smirnova
I. S. Smirnova
JOJu. V. Obidina
Ju. V. Obidina
NNN. N. Nikolsky
N. N. Nikolsky
The present study focuses on the involvement of reactive oxygen species (ROS) in the process of mesenchymal stem cells “waking up” and entering the cell cycle after the quiescence. Using human endometrial mesenchymal stem cells (eMSCs), we showed that intracellular basal ROS level is positively correlated with the proliferative status of the cell cultures. Our experiments with the eMSCs synchronized in the G0phase of the cell cycle revealed a transient increase in the ROS level upon the quiescence exit after stimulation of the cell proliferation. This increase was registered before the eMSC entry to the S-phase of the cell cycle, and elimination of this increase by antioxidants (N-acetyl-L-cysteine, Tempol, and Resveratrol) blocked G1–S-phase transition. Similarly, a cell cycle arrest which resulted from the antioxidant treatment was observed in the experiments with synchronized human mesenchymal stem cells derived from the adipose tissue. Thus, we showed that physiologically relevant level of ROS is required for the initiation of human mesenchymal stem cell proliferation and that low levels of ROS due to the antioxidant treatment can block the stem cell self-renewal.